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Abstract 
A model is presented visualizing the events leading 
to calcium-salt, crystal- and stone-formation inside the 
nephron. For each nephron segment, handling of urine 
components relevant to stone formation is considered 
and urine composition determined. This information 
was applied to nucleation experiments simulating passage 
of urine through a nephron. The model and in vitro ex-
periments suggest that within normal transit times for the 
respective nephron segments, particles of a hydroxyapa-
tite-like material first form near the bend in the Loop of 
Henle of juxtamedullary nephrons. From there on, cal-
cium oxalate particles start to appear: first dihydrate, 
then monohydrate. In the collecting duct system, parti-
cle size increases primarily due to crystal agglomeration. 
Several conclusions with clinical and experimental rele-
vance can be drawn. An increase in urinary volume 
does not decrease the chance of crystal formation in the 
Loop of Henle, but does decrease passage time through 
the collecting ducts, and thus, the time allowed for large 
particle formation. A calcium load does not increase the 
risk for nucleation up to the distal tubule, but does in-
crease the risk of large particle formation in the collect-
ing ducts. An oxalate load increases the chance for nu-
cleation throughout the nephron. For experiments simu-
lating crystalliz.ation processes occurring inside the ne-
phron, diluted urines should be used. They should be 
diluted 16 to 50 times for testing nucleation, 2 to 30 
times for testing crystal growth, and 2 to 20 times for 
testing crystal agglomeration. Undiluted urines may be 
used to mimic conditions in the pelvis and the bladder. 
Key Words: Crystalliz.ation, calcium oxalate, uro-
lithiasis, nephron. 
471 
Introduction 
Crystalluria, the formation of particles which flow 
freely with the urine, is common for most people. 
However, formation of a particle which is not excreted 
freely, urolithiasis, occurs only in 5 to 9% of the popu-
lation. Theoretically, and as seen in animal experi-
ments, the step from a free particle to a stone probably 
involves particle retention (20, 31, 35, 36]. This may 
be a fixed particle mechanism, fixation of particles to 
the nephron wall or trapping in sites with poor flow-con-
ditions, a free particle mechanism, formation of particles 
too large to be excreted freely, or a combination. Ideal-
ly , the fixed particle mechanism is preferred up to the 
late distal tubule. However, under hyperoxaluric condi-
tions, a free particle mechanism seems to occur in the 
proximal tubule (31] . In the collecting ducts and the 
duct of Bellini, both a fixed and a free particle mecha-
nism are likely [35]. The chances for the latter are es-
pecially increased by the size increasing process known 
as crystal agglomeration [35]. A role for crystal agglo-
meration in stone formation has been subscribed by ex-
perimental data. Urine contains numerous compounds 
capable of effecting crystal agglomeration [ 17, 25, 38, 
60] . The ability of urine to inhibit crystal agglomeration 
is decreased in stone formers (19, 37, 40]. This may be 
due to a low citrate excretion (19, 27, 37, 40], or aber-
rant action of urinary proteins like crystal matrix protein 
(60], Tamm-Horsfall protein (THP) and nephrocalcin 
(NC) [22, 26, 58]. 
A problem with these in vitro data is that the test 
conditions may not reflect the conditions at the site of 
stone formation. But, what are those conditions? It 
appears obvious that crystalliz.ation experiments should 
be performed using whole, undiluted urine. However, 
whole undiluted urine is such a strong inhibitor of crys-
talliz.ation processes that for crystalliz.ation to take place, 
usually extra calcium or oxalate has to be added [50, 
54]. This makes one wonder how any crystals could 
ever form in urine. Then, there is the phenomenon of 
patients who comply very well to their drinking advice 
and produce high volume urines. Often, these urines 
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have saturation levels so low that nucleation occurs only 
after very prolonged times or not at all. Still, these 
patients may continue forming stones. 
The answer to these questions may lie in the kidney 
function. A kidney daily concentrates a large pool of 
filtered plasma to a relatively small volume of urine, in 
the process, removing and adding compounds which play 
a role in stone formation. During its passage through 
the nephron, the composition of the urine continuously 
changes and differs greatly from that of the pelvic urine. 
Further addition of compounds and cellular debris in the 
pelvis and bladder complete the final composition. In 
this paper, I try to model the changing conditions along 
the nephron and relate these to the chance of particle and 
stone formation inside the nephron. For most parame-
ters relevant to urolithiasis, these changes under normal 
physiologic conditions per nephron segment are well de-
scribed or can be assessed reasonably. The parameters 
included here are calcium, oxalate, citrate, phosphate, 
uric acid, sodium, potassium, chloride, magnesium, NC, 
pH, THP and volume. The following questions are ad-
dressed: where is crystallization most likely to start; 
what are the roles of calcium phosphate and calcium ox-
alate crystallization and of kidney anatomy; where and 
how do alkali-therapy, protein-, calcium- or oxalate-
restriction, and drinking advice influence the risk for 
stone formation; what is the most realistic way for test-
ing urine samples: in vitro, undiluted or diluted? 
Abbreviations Used and Nephron Segmentation 
The nephron is subdivided into proximal tubule; 
Loop of Henle (LH): descending (DLH) and ascending 
(ALH), short and long (SDLH, LDLH, SALH and 
LALH); distal tubule (without connecting tubule seg-
ment, CNT); outer and inner medullary collecting duct 
(OMCD and IMCD); duct of Bellini, and collecting duct 
system (CD, consisting of CNT + OMCD + IMCD + 
DOB). Abbreviations used are: TF/P and TF/UF, con-
centration ratios of tubular fluid to plasma and plasma 
ultrafiltrate respectively; THP, Tamm-Horsfall protein; 
NC, nephrocalcin; COM, calcium oxalate monohydrate; 
HAP, hydroxyapatite; UA, uric acid. The distal tubule 
referred to in micropuncture studies includes the CNT, 
which differs in properties from the true distal tubule, 
especially in its capacity to resorb water. Here, the 
CNT is included in the CD. 
Data Used 
Concentration limits and conditions per nephron-seg-
ment are calculated using limit-values for 24-hour excre-
tion, plasma and ultrafiltrate concentrations and percent 
resorption/excretion per segment, mostly from ref. [9], 
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Table 1. A distinction is made between superficial and 
juxtamedullar nephrons. The latter have a larger glo-
merulus diameter, longer LH with a thin segment, dif-
ferent resorption characteristics, and in humans, consti-
tute 14% of the nephrons. The values are compared to 
micropuncture data [54], which usually describe the 
proximal tubule and distal tubule of superficial nephrons 
and the LH of juxtamedullary nephrons. Conditions in 
the proximal and distal tubule of juxtamedullary neph-
rons and the LH of superficial nephrons must be assess-
ed by extrapolation. 
Volwne 
Per minute, 125 ml serum is filtered , yielding 58 
ml/min filtrate per kidney and a total of 167 1/24 hr. 
Volume is reduced by reabsorption of water in three 
compartments of the nephron: the proximal tubule, the 
DLH and the CD to the daily urine volume of 0.6 to 7 .5 
liters (0.2 to 2.6 ml/min per kidney). During short time 
periods, flows up to 5.8 ml/min can be sustained. The 
fine regulation related to dietary load occurs mainly in 
the CD. Micropuncture studies in superficial nephrons 
show that 35 % of the filtered load leaves the proximal 
tubule and 20% enters the distal tubule [9, 54] . Thus, 
15 % is resorbed in the SDLH. In juxtamedullary neph-
rons, the TF /P inulin ratio at the bend of the LH at the 
papillary tip averages 1: 11. 3, with extremes up to 
1:18.1. Thus, volume is reduced to between 9 and 5% 
[21 , 29, 42]. When the proximal tubule of juxtamedul-
lary and superficial nephrons act alike, 65 % resorption, 
then the LDLH resorbs 26 to 30% of the filtered load. 
These numbers probably are underestimates of the true 
concentrating capacity. In micropuncture experiments, 
exposure of the papilla results in a loss in concentrating 
capacity of up to 57% [44, 53, 57], probably because 
urea can no longer diffuse from the pelvic urine to the 
medullary interstitium, diminishing the effectivity of the 
countercurrent mechanism. Resorption up to the CD is 
fairly independent of the diuresis state, depending mainly 
on glomerular filtration rate. Regulation from the 5 to 
20 % , leaving the distal tubule to the daily end volume, 
occurs in the CD (Table 1). 
Calciwn, sodiwn, magnesiwn, chloride 
The normal values for UFNa• UFc1, UFca and 
UFMg are 145 mM, 122 mM, 1.45 mM and 0.53 mM. 
The 24-hr excretion ranges (mmoles) I used are 50 to 
400 Na, 50 to 400 Cl, 0.5 to 22 Ca and 0.5 to 10 Mg. 
Dietary loading with these compounds does not affect 
filtered load, but is regulated in the distal tubule and 
first part of the CD. In superficial nephrons in rodents, 
at the end of the proximal tubule, TF /UFNa averages 
1.03, TF/UFc8 1.2, TF/UFMg 1.8 [1, 15, 43, 45, 48, 
62]. In the SDLH, no resorption of Na and Ca occurs. 
In the LDLH, volume is reduced 4 to 7 times compared 
Urolithiasis 
Table 1. Concentration and excretion ranges in plasma (mM), ultrafiltrate (mM) and 24-hr urine (mmoles, low and 
high end of the ranges), own data and [9, 54). 
Vol,! Ca ox.103 PO4 Na K Mg UA cit 
Plasma -- 1.58-5 0.5-50 0 .4-2 136-145 3 .6-4.8 0 .6-1.2 0.17-0.30 0.087-0 .147 
Ultrafilt. - 1.02- < 3*l o.5-5o*2 0.48-2.4 136-145 3.6-4.8 0.45-1.00 0 .17-0.30 0.087-0 .147 
24-hr, low 0.6 0.5 100 5 45 20 0.5 2 0.1 
24-hr, high 7.5 7.5 2000 75 582 260 12.5 10 7.5 
•t At high plasma calcium concentrations the ultrafiltrability decreases due to the formation of calcium phosphate nuclei 
in the plasma. 
*2With normal renal function a plasma oxalate concentration of 10 µM is the maximum, with impaired renal function 
in hereditary hyperoxaluria, values up to 50 µM can be found. 
---------------------------------------------------------------------------------·---
to the end proximal tubule. Thus, TF /UFNa should 
reach 4.12 to 7.21. Measured TF/UFNa values at the 
bend of long LH, however, average 2.2 to 2.6 [13, 29), 
with extremes up to 6 [13). It appears that 35% of the 
NaCl load entering the LDLH (12 % of the filtered load) 
is reabsorbed in the upper portion of the DLH [61) . 
Micropunctures of LDLH before the bend showed 
an average calcium concentration of 3 mM [28). In 
light of the accompanying TF/P inulin values of 6.63, a 
calcium concentration of 4.1 mM would be expected. 
Thus ± 1 mM was reabsorbed, presumably in the upper 
portion of the LDLH. The maximum calcium concen-
tration, when no further reabsorption occurs in the thin 
segment, will be 5 .1 to 8.1 mM in loops where the 
TF IP inulin reaches 11. 3 to 18. Comparable estimates 
of calcium concentrations are obtained when I assume 
that calcium and sodium are handled similarly. When 
35 % of the load entering the LDLH is reabsorbed, con-
centrations reach 4.6 to 8.05 mM. Reabsorption of Na, 
K, Mg, Ca and Cl in the ALH occur with equal effi-
ciency, mainly in the thick part. In superficial neph-
rons, TF/P values for Na, K, Mg, and Ca reach 0.5, 5, 
0.6 and 0.5 respectively at the early distal tubule and 
0.2, 0.2, 0.3 and 0.2 at the late distal tubule [2, 54). 
For juxtamedullary nephrons, these numbers are as-
sumed here to be the same or higher. 
Potassium 
UFK is 3.6 mM. The regulation of Kand Na dif-
fers especially in the LDLH. There, K is secreted, re-
storing it to approximately the filtered load. The K con-
centration in the LDLH is assumed to approach that in 
SALH as the urine enters the distal tubule. The amount 
of potassium entering the distal tubule is increased to the 
final pelvic urine value by active secretion. The resorp-
tion occurring in juxtamedullary LALH is not known. 
It is assumed here that the resorption process itself is 
equally efficient in short and LALH. The resorption in 
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LALH is thus calculated as (length short loop) I (length 
long loop) times resorption in short loops: (18/6) * 27 = 
81 %. 
Phosphate 
UFro4 averages 3.4 mM, ranging up to 4.7 mM. 
Below the reabsorption threshold, TF /Pro4 falls to 0. 7 
in the proximal tubule [54), 75% reabsorption, 10% is 
reabsorbed in the distal tubule and 3 to 7 % in the CD 
f23, 24, 521. Above the threshold, increases in filtered 
load are excreted quantitatively. 
Oxalate 
Plasma oxalate concentration in humans averages 2 
µM and varies with loading. In hyperoxaluric patients 
with normal renal function, a basal value of 5 µM is 
found. With impaired renal function, levels may reach 
50 µM [65). Oxalate reabsorption and secretion seems 
to occur in the proximal tubule. No clear quantitation is 
available for this. I assume all oxalate enters the neph-
ron at the glomerulus. This affects the validity of the 
model for extreme situations where nucleation occurs in 
the proximal tubule. Upon dietary loads, the excretion 
in controls increases up to 290 % over fasting values, 
from 0.011 to 0.033 mmole/hr [5]. When 167/24 = 
6.96 liters of plasma is filtered per hour, this corre-
sponds to plasma oxalate concentrations of 1.58 and 4.6 
µM. Stone formers reportedly reacted twice as strongly 
to acute loads, plasma oxalate values reaching 5 times 
the reported fasting value of 1.6 µM [5]. 
Uric acid 
Uric acid is reabsorbed and secreted in the proximal 
tubule; 7 to 12 % reaches the final urine, determined by 
the daily purine load [9]. 
pH 
Micropuncture data from superficial nephrons shows 
that pH is lowered from 7 .4 in the plasma to 6 . 7 in the 
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Table 2. Conditions employed in nucleation experiment to simulate parameters at the end of a given nephron segment. 
The end values for DOB are based on high normal values for calcium and oxalate and a urine volume of one liter. 
added total time pH Ca 
ml ml sec mM 
PROX 0.5 0.5 0 6.7 1.35 
LDLH 0.5 1 40 7.26 7.9 
LALH 5.85 6.85 100 6.65 1.35 
DISTAL 16 22.85 31 6.38 0.75 
Duct of 7.15 30 50 6.16 7.5 
Bellini 
proximal tubule, and is 6. 7 in the early distal tubule. 
When the urine is concentrated by water resorption in 
the DLR, the concentrations of CO2 and bicarbonate in-
crease. Some CO2 diffuses to the interstitium, resulting 
in an increased pH. In the LDLH, pH is increased to 
7.4. For the SDLH, no data is available. However, 
when I assume the increase is related to the concentrat-
ing efficiency, which is two times lower in the SDLH, 
pH will reach 7 .1 to 7 .2. The pH is brought to its end-
value in the distal tubule and CD. 
Relative supersaturation (RS) 
The RS for COM, UA, brushite and HAP is calcu-
lated using EQUIL [63], adapted with values for activity 
constants and COM-solubility determined in our labora-
tory [7, 34]. 
Nephrocalcin (NC), Tamm-Horsfall protein (THP) 
The production site for NC is unknown. lmmuno-
histochemically, it can be found in the proximal and dis-
tal tubule. I assume the average daily excretion, 1.9 
µmoles, originates half from each site and that NC is not 
reabsorbed in the nephron. THP is localized in the 
ALH and early distal tubule. The total amount present 
is assumed to increase from zero entering the ALH to 
the average 24-hr value of 0.5 µmoles at the middle of 
the distal tubule. 
Crystalli:iation experiments 
The effects of urine on COM-crystallization kinetics 
are determined with a well-established seeded crystal 
growth system in which uptake of 45Ca by aged and pre-
grown crystals is measured [6, 8, 64). Two types of ex-
periments are performed. In the first, the starting super-
saturation is constant but growth time is varied. In the 
second, growth time is constant, while the starting calci-
um oxalate concentration product is varied around the 
expected solubility. Solubility is then measured as the 
lowest concentration product after which uptake of 45ca 
due to crystal growth occurs. From the kinetic experi-
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ox PO4 Na Cl Mg CIT 
mM mM mM mM mM mM 
0.009 1.35 151.5 154.7 0.99 0.03 
0.05 8 408.7 423.8 4 0.2 
0.05 8 158.7 153.9 0.59 0.2 
0.05 3.2 48.9 47.1 0.3 0.2 
0.5 42 199 175 5 2 
ment, the crystal growth and crystal agglomeration pa-
rameters are calculated using a complete description of 
COM-crystallization kinetics as described extensively 
previously [6, 8, 64]. The solubility {(VLc in mM), 
where Le is the solubility product based on concentra-
tions}, growth inhibition(% G.I.), and agglomeration 
inhibition {(tm)/(tm)c) of COM-crystals are measured as 
three separate, system-independent parameters. The 
latter two are relative to a control experiment. The 
urines were tested undiluted. 
Undiluted urines 
Undiluted urines were made under-saturated, requi-
red for measuring solubility, by dialyzing overnight 
against chelex, a cation chelating column material. This 
removes all Ca and Mg. Magnesium is restored to its 
original concentration and the solubility is measured. 
The removal of tracer ions has no effect on the solubility 
[34]. For the kinetic experiment, untreated undiluted 
urine was used directly or with 1.2 mM oxalate added. 
Measurement of the nucleation lag-time 
The nucleation lag-time(,) was measured according 
to [3]. Supersaturated solutions were prepared by mix-
ing a cation and an anion buffer into a polystyrene cu-
vette. The cation buffer contains calcium, magnesium, 
sodium, potassium and chloride. The anion buffer con-
tains urate, chloride, phosphate, citrate, oxalate, sodium 
and optionally bicarbonate. The compositions of the 
buffers are chosen such that in the mixture concentra-
tions, ionic strength and pH resemble those around the 
bend of a LH. For a short loop, the concentrations 
were as follows: 2.99 mM Ca, 4.5 mM or 16 mM PO4, 
0.01 mM oxalate, 252 mM Na, 21 mM K, 2.26 mM 
Mg, 0.132 mM urate, 0.08 mM citrate, pH 7.19, 7.20 
and 7.21 and Cl as rest ion. For a long LH, the con-
centrations used were: 7. 9 mM Ca, 8 mM phosphate, 
0.05 mM oxalate, 408. 7 mM Na, 80 mM K, 4 mM Mg, 
0.432 mM urate, 0.331 mM citrate, pH 7.29 and Cl as 
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Figures 1 (at left) and 2 (at right). Changes in total volume per nephron segment for four 24-hr urine volumes (Fig. 
1) and the relative dilution per segment as compared to the final total volume (Fig. 2): 0.6 (squares), 1 (diamonds), 
2 (circles) and 7.5 liters (triangles). 
rest ion. In some experiments, 47 mM bicarbonate was 
added. There, urate had to be left out. When simulat-
ing the conditions around the bend of the LH, it is as-
sumed that the changes occurring in the descending and 
ascending limb are linear. Thus, the change per unit 
length is obtained by dividing the total change by the 
length of the limb. For instance, when the amount of 
water resorbed in the D LH is put at 100 % , 7 5 % is as-
sumed to be resorbed, when 75 % of the distance to the 
bend has been traversed. 
The OD590 (optical density measured at 590 nm) is 
measured during ten minutes in a spectrophotometer. 
When particles are formed, an apparent absorption oc-
curs due to particle-induced light scattering. The onset 
of this absorption is taken to be r. Actually, this will 
slightly overestimate the real value. After 5 or 10 min-
utes, a sample was filtered over 0.05 µm Nucleopore fil-
ters. The filters were then gold-coated and analyzed us-
ing a 525 M Philips (Eindhoven, Netherlands) scanning 
electron microscope (SEM) operated at 15 kV. 
Nephron nucleation system 
The conditions in the nephron change continuously. 
The precipitation processes occurring under these chang-
ing conditions were tested in the dynamic nucleation 
system. In this nucleation system, the composition of 
the experiment is changed continuously (Table 2) by 
adding a series of different buffers. At time z.ero, 0.25 
ml of an anionic and cationic buffer are combined under 
rapid mixing. The starting conditions in the mixture 
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represent what is present in the proximal tubule. A 0.01 
ml sample is taken at time z.ero and filtered immediately 
over 0.05 µm nucleopore filters. Then, buffers are 
added gradually until at time = 40 seconds the condi-
tions resemble those present at the bend of a long LH. 
A sample is taken at 40 seconds, and new buffers are 
added, working towards the conditions present at the end 
of the ALH. This process takes 100 seconds. Then, a 
sample is taken at 140 seconds (100 + 40) and new 
buffers are added, etc. Total addition time is 221 sec-
onds. After this, no more buffers were added. The so-
lution was kept mixed and samples were taken at 240, 
300 and 600 seconds. The solution is kept at a fixed 
stirring rate in a double-walled round-bottom vessel at 
37°C. The buffers are added at opposite vessel-sides, 
using multi-channel peristaltic U202 Whatson Marlow 
(Falmouth, Cornwall, U.K.) pumps. The filters were 
gold-coated and analyzed using SEM. 
Results 
Total volume and dilution factor 
The total volume per nephron segment decreases, 
moving from the glomerulus to the pelvic area (Fig. 1). 
Four examples were used representing low, 0.6 l; aver-
age, 1 and 2 l; and high 24-hr volumes, 7.5 l. For in 
vitro experiments, it can be seen that relative to the 24-
hr volume, urine needs to be diluted 2 to 20 times to 
simulate conditions in the CD, where agglomeration may 
be most important [35], and 16 to 50 times to simulate 
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Table 3. Standard dilution for in vitro experiments. 
24-hr 
vol. 
0.5 
1 
1.5 
2 
3 
5 
Dilution 
OMCD 
21.4 
10.9 
7.4 
5.6 
3.9 
2.5 
Dilution 
IMCD 
5.4 
3.2 
2.4 
2.0 
1.6 
1.3 
Figures 3, 4 and 5 at right. 
Figure 3. Seeded crystal growth experiment using 
whole undiluted urine directly (squares) or with 1.2 mM 
oxalate added (circles) . Hollow and filled symbols rep-
resent two consecutive experiments with the same urine. 
Ut is the fractional uptake of calcium into the crystal 
mass. 
Figure 4. Nucleation lag-times (squares) in solutions 
representing the conditions around the bend of a long 
Loop of Henle. On the x-axis is given how far the point 
is removed from the bend, depicted as 0. The units are 
% of the DLH on the left side of the bend and % of the 
ALH on the right side of the bend. The diamonds rep-
resent the surplus time, the transit time from the point of 
measurement to the end of the LALH minus the lag-time 
at that point. When the surplus time is positive, there is 
sufficient time for nucleation to occur. 
Figure 5. Increasing doses of phosphocitrate were add-
ed to solutions representing the situation at the tip of a 
long Loop of Henle (Table 2, but with 10 mM PO4, dia-
monds) , phosphocitrate was added in increasing doses at 
different pH-values: 0.5 µM (circles), 2.5 µM (trian-
gles), 5 µM (crossed squares), 25 µM (crossed circle). 
conditions in the DLH and ALH, where nucleation may 
occur first (Fig. 2). The dilution factor in the CD de-
pends on the end volume (Table 3). In the distal tubule, 
urine flow is fairly constant: 5.8 ml/min per kidney or 
16. 7 liters per day [35] . Concentration to the final 
volume takes place in the OMCD and IMCD. The fol-
lowing formulae are obtained assuming resorption occurs 
evenly over the total length of both segments 16 mm 
(OMCD) and 6 mm (IMCD) [35]: volume removed 
equals: 16.7 - 24-hrvolume; volume at midpoint OMCD 
equals: 16.7 - (16 .7 - x)(22/8); volume at junction 
OMCD/IMCD equals: 16. 7 - (16. 7 - x)(22/16); volume 
at midpoint IMCD equals: 16. 7 - (16. 7 - x)(19/22). Of 
this concentration, approximately two-thirds occurs in 
the OMCD and one-third in the IMCD. Thus, the urine 
should be diluted in the above-mentioned manner. 
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Table 4. TF/UF-values at end of each segment. 
.UF Proximal SDLH LDLH SALH LALH sup. distal juxt. distal CD 
1 0.35 0.20 0.05-0.09 0.20 0.05-0.09 0.20 0.05-0.09 0.004-0.045 VOL 
1 1.22 2.1 3.2-5.6 0.52 0.52 0.21-0.52 0.21-0.52 0.07-21 Ca 
1 3.5 5 11-20 5 11-20 5 11-20 250 ox 
1 0.75-1.2 1.3-2.1 2.9-8.4 0. 75-2.1 0.75-8.4 0.5-2.1 0.5-8.4 0.5-90 PO4 
1 1.03 1.8 2.2-6 0.5 0.5 0.2 0.2 0.04-6.7 Na 
1 1.1 5 10-20 5 10-20 0.2 0.2 0.6-100 K 
1 1.8 3.1 7-12.6 0.55 0.55 0.21-0.55 0.21-0.55 0.07-21 Mg 
1 0.2-0.4 0.35-0.7 0.8-2.8 0.35-0.7 0.8-2.8 0.35-0.7 0.8-2.8 0.8-40 UA 
1 0.06-0.85 0.1-1.4 0.2-6 0.1-1.4 0.2-1.4 0.1-1.4 0.2-6 0.4-83 CIT 
7.25 6.7 7.1 7.4 6.7 6.7 * * - pH 
0 0 0 0 50 50 0 0 0 THP 
0 50 0 0 50 50 0 0 0 NC 
*The regulation of pH to its end-value occurs in the distal tubule [9]. 
--------------------------------------------------------------------------------------------
Concentrations 
Table 4 shows the changes along the nephron for 
Ca, Na, Mg, oxalate, PO4, K, UA, citrate, pH, NC and 
THP. High normal values for Ca- and oxalate 24-hr 
excretion and a 24-hr volume of 2 liters were used. 
Crystal growth and agglomeration 
In undiluted urine, measurable 45Ca-uptake occurred 
only after addition of 1.2 mmoles/liter oxalate (Fig. 3). 
Nucleation lag-times 
In Figure 4, T is shown for solutions simulating the 
conditions around the bend of a long LH (Table 2). 
Coming from the end proximal tubule conditions, where 
concentrations approach 75 % of those at the bend of the 
LH, r falls within the remaining passage time of urine 
through the loop, 140 seconds for the total loop [35]. 
When the solution is diluted from the bend-conditions to 
early distal tubule conditions, r increases strongly after 
40 % of the ALH has been traversed. The precipitate is 
a HAP-like material. Addition of bicarbonate further 
decreases r, suggesting a carbonate-containing type of 
HAP. When conditions in a short LH are simulated 
(2.99 mM Ca, 4.5 mM PO4, pH 7.2), T exceeds 300 
seconds. With 2.99 mM Ca, 16 mM PO4, pH 7.2 (high 
phosphate load), Tis 40 seconds. The lag-time is very 
dependent on the pH, decreasing 8-fold when pH in-
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creases from 7 .19 to 7 .22. During the lag-time period, 
pH did not change. When low doses of phosphocitrate 
were added to solutions representing the bend of a long 
LH (Table 2, LDLH with 10 mM PO4), r increased 
greatly (Fig. 5). 
Nephron nucleation 
Samples were taken at 40, 140, 171, 221, 240, 300 
and 600 seconds and analyzed using a SEM. At 40 sec-
onds, rounded particles, that are 0. 7 µm in diameter, are 
found, mainly as aggregates up to 6 µm large (Fig. 6). 
By infrared analysis, the material was characterized as 
HAP. After 140 seconds, representing the end of the 
LALH, single COD-crystals, 2 µm, and agglomerates, 
up to 4.4 µm, start to appear. At 171 seconds, leaving 
the distal tubule, both COD and COM can be found. At 
221 seconds, agglomerates up to 7 µm, and after 600 
seconds, large, 15-30 µm, COM-agglomerates and COM 
rosettes are found (Fig. 7). 
Discussion 
Crystal formation is an essential first step in stone 
formation. However, while crystalluria is common in 
both healthy subjects and stone formers [18, 46, 55], the 
step from a harmless free flowing crystal to formation of 
a stone occurs in only 5 to 9 % of the population. A 
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Figure 6. A scanning electron micrograph of the material which precipitates in the conditions existing at the tip of a 
long Loop of Henle as described in Table 2. By infrared analysis, the material was shown to be HAP. Bar = 10 µ.m. 
-------------------------------------------------------------------------------------
particle causes harm when it's size approaches the di-
mensions of the urinary tract it is passing through or 
when it adheres to the cell linings, free and fixed parti-
cle mechanism respectively [20, 35]. Important factors 
in this respect are: processes increasing particle size 
(crystal growth and agglomeration), stickiness of parti-
cles and cell lining, architecture of the kidney, the site 
of nucleation, and transit time through the kidney. Pre-
viously, we have shown which retention mechanisms 
play a role in specific parts of the nephron [35] and how 
crystal agglomeration poses a risk factor in urolithiasis 
[19, 35, 36, 37, 40] . Remaining questions were: do 24-
hr urine samples mimic the actual situation at the site of 
stone formation; where does nucleation start in the neph-
ron; where do dietary factors and commonly used thera-
pies intervene? Here, I modeled the chances of crystal 
formation per nephron segment and their dependence on 
factors such as diet and medical therapy. The literature 
data used for this model are obtained from micropunc-
ture studies using dog, rat and rabbit. These data cannot 
be extrapolated directly to the human situation, which 
should be kept in mind while evaluating the model. To 
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increase the validity of the model, ranges of concentra-
tions etc. were used which may comprise those occur-
ring in humans. 
It is clear from the model that under normal condi-
tions, no crystal formation occurs in the proximal tu-
bule. Total volume is reduced by 65 % , but stone com-
ponents are removed too. As a result, the urine general-
ly remains too dilute. Crystal formation in the proximal 
tubule occurs only with a high oxalate or uric acid 
filtered load, as witnessed in animal studies [31]. Mov-
ing into the LH, a distinction must be made between su-
perficial and juxtamedullary nephrons. In the first, 
urine is concentrated to 20% of the filtered load. For-
mation of crystals occurs only with moderate increases 
in phosphate load or strong increases in oxalate or uric 
acid load, and at pH values over 7 .20. At the bend of 
the LDLH, however, urines are concentrated much 
more, to 5-9 % of the filtered load and pH reaches 7.4. 
It was shown previously that under the conditions exist-
ing at the bend of the LDLH, an apatite-like material is 
found after 1 hour [14]. I have confirmed here that a 
HAP-like material, probably containing carbonate, is 
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Figure 7. A scanning electron micrograph of the crystal material present in the nephron nucleation system after 600 
seconds. Bar = 10 µm. 
formed under conditions routinely present in the LH of 
juxtamedullary nephrons. The nucleation lag-times fall 
well within the passage time through the long LH. The 
sizes of single particles (0. 7 µm) and agglomerates (6 
µm) formed are small relative to the inner diameter of 
the ALH (19-29 JLm) . However, the experiments were 
performed under relatively high shear forces . In vivo, 
these forces may be smaller, allowing for larger agglom-
erates to be formed. It was concluded before [47] that 
while calcium-phosphate is nucleated in the LH, calcium 
oxalate nucleation is more likely to occur in the later 
parts of the nephron. For calcium oxalate nucleation to 
occur within the time-frame of the loop passage (140 
seconds), a relative supersaturation of 28 is required [3] . 
The calcium concentration in a specific loop is relatively 
constant in time, depending mainly on the resorption-ef-
ficiency of that loop. When, in my calculations, I take 
a range of possible calcium concentrations in different 
loops (2, 4, 6 or 8 mM), the oxalate values needed for 
a RS of 28 are 0.39, 0.195, 0.13 or 0.097 mM. For a 
short loop, concentrating 5 times, 390 and 195 µM oxa-
late loop-concentrations correspond to plasma values of 
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78 and 39 µM. For long loops concentrating 11.1 
times, loop concentrations of 130 and 97 µM correspond 
to plasma oxalate values of 11. 7 and 8. 7 µM. For long 
loops concentrating 20 times, a loop concentration of 97 
JLM corresponds to a plasma value of 4.9 µM . 
Thus, in juxtamedullary nephrons, HAP nucleation 
may occur routinely. This is also seen in in vivo experi-
ments in rat models of nephrolithiasis , where calcium 
phosphate crystals preferentially deposit at the LR/proxi-
mal tubule junction [30, 49] and calcium oxalate nuclea-
tion occurs when plasma oxalate exceeds 5 JLM . Normal 
fasting plasma oxalate concentrations (2 µM) are insuffi-
cient. Upon acute oxalate dietary loads, the urinary ox-
alate excretion rate in normal controls increases up to 
290%, from 0.011 to 0.033 mmole per hour [5]. As-
suming that 167/24 = 6.96 liters of plasma is filtered 
per hour, this corresponds to plasma values of 1.58 and 
4.6 µM . Stone formers are reported to react stronger to 
acute loads, with maximum plasma oxalate values reach-
ing 5 times the fasting value [11]. With a fasting 
plasma oxalate of 2, this would imply a peak plasma 
value of 10 µM. In hereditary hyperoxaluria, fasting 
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plasma oxalate values approach 5 µM. Nucleation re-
quirements may be met under acute oxalate loading in 
normals and more likely in stone formers. In hyperoxal-
uria, calcium oxalate nucleation in the LH or earlier 
seems inevitable. In the most severe conditions, heredi-
tary hyperoxaluria with renal impairment, plasma oxa-
late values may reach 50 µM and calcium oxalate crys-
tals are found at the end proximal tubule already. The 
same is seen in rat studies where oxalate excretion is in-
creased 6 times by administration of oxalate or ethylene 
glycol [35] . In these severe cases, calcium oxalate crys-
tals are found also in other organs like the skeleton. 
This would imply that calcium oxalate nuclei circulate in 
the plasma. However, since the crystals are not found 
in the early proximal tubule, it is more likely that the 
nucleation is locally triggered. 
Thus, thermodynamically, nucleation is likely to 
occur in the LDLH within the required time-frame. 
However, nucleation kinetics may be affected by other 
means. Nucleation lag-time can be decreased by mem-
branous material [33] or crystal matrix protein [59] or 
increased by inhibitors like citrate, magnesium and NC 
[4]. However, when all low molecular weight com-
pounds were included at the concentrations occurring in 
the LDLH, nucleation lag-times were still within transit 
times. NC was not included. NC can decrease the rate 
of secondary calcium oxalate nucleation by 42 % at a 
concentration of 0.2 µM [4]. The concentration of NC 
in the LDLH will be between 0.016 and 0.097 µM, thus 
below its effective concentration range. The lag-time 
for HAP nucleation in the LDLH is below 3 seconds, 
compared to a transit time of 140 seconds for the total 
loop. As was shown here with phosphocitrate, low con-
centrations of effective inhibitors could delay nucleation 
long enough to allow safe passage of the LH. Theoreti-
cally, such compounds can postpone the nucleation risk 
to the late distal tubule and collecting duct system. 
The sizes of particles formed up to the distal tubule 
seem too small to allow a free particle mechanism. Re-
tention in the LH would require adherence to the cell 
lining. In this respect, it will be interesting to inves-
tigate if the presence of a compound like THP [41] or 
crystal matrix protein [60] in the coat of tubular cells in 
the ALH interferes with crystal-cell adhesion. Down-
stream through the ALH and further, conditions become 
less favorable for HAP crystallization and calcium oxa-
late crystals appear. Interestingly, in the in vitro experi-
ments, the amount of HAP material seems to diminish. 
THP now enters the urine and may interfere with calci-
um oxalate nucleation together with compounds like NC. 
The HAP nuclei may thereby act as heterogeneous nu-
cleators for calcium oxalate [16]. First, COD is found, 
then also rosettes and agglomerates of platelet-like 
COM. Up to the conditions simulating the CD, the sin-
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gle particles are approximately one-tenth the size of the 
inner diameter of the segments they are passing through. 
However, within the transit time from the nucleation-
site, the bend of the LH, to the end of the Duct of Bel-
lini, 181 seconds under low diuresis, larger COM-ag-
glomerates are formed in the collecting duct conditions. 
Kidney architecture favors agglomeration to take place 
in the CD, where crystals originating from some 4000 
nephrons meet in one collecting duct. The agglomerates 
will include organic material [32] and the process will be 
influenced by compounds not included here like THP 
and NC. These events occur already at high normal cal-
cium, phosphate and oxalate excretion rates of 7.5, 42 
and 0.5 mmoles/24 hr respectively and a total volume of 
one liter. Under more extreme acute loading conditions, 
concentration of oxalate may increase two-fold, and that 
of phosphate four-fold, in the LH. Precipitation then 
also may occur in the superficial nephrons, further en-
hancing the chance of big particle formation in the col-
lecting ducts. 
A distinction between two types of nephrons also 
occurs in animal studies where mild crystalluria is in-
duced using 0. 75 % ethylene glycol and 2 % ammonium 
chloride. There, crystals are found in a restricted 
number of collecting ducts [31, 35]. It is not known 
whether this stems from differences in the type of neph-
rons discharging into the collecting ducts. 
The model and experimental data lead to several 
simple but surprising conclusions. The first concerns 
the question as to how urine should be tested in in vitro 
crystallization experiments. Usually, it is assumed that 
using untreated and undiluted urine mimics the situation 
at the site of stone formation. Surprisingly, when undil-
uted urines are tested, it is seen that crystallization 
proceeds at an extremely low rate. Only when urine 
was ultrafiltered, removing high molecular weight com-
pounds, diluted, or when extra oxalate was added did 
appreciable crystallization occur. If undiluted whole 
urine is representative for the site of stone formation, it 
is hard to imagine how crystals, let alone even large par-
ticles, could ever form. From the model, it follows that 
using undiluted urine actually simulates events in the 
bladder and the pelvic area. The situation inside the 
nephron is much different. From the site where nuclea-
tion starts, the DLH, the following events (relevant for 
stone formation) occur: water is reabsorbed, causing 
concentration of compounds which are not reabsorbed, 
such as NC, oxalate and citrate; calcium may be reab-
sorbed and pH reduced, and proteins like THP enter the 
solution. Thus, if you want to mimic the situation inside 
the nephron, you need to add water and calcium, in-
crease pH, etc. For testing crystal agglomeration and 
growth occurring in the OMCD, IMCD and duct of Bel-
lini, the collected urine should be tested at 1: 2 to 1: 20 
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dilutions after addition of up to 5 times the 24-hr amount 
of calcium and at pH values higher than the 24-hr urine 
pH. For testing nucleation and crystal growth in the 
ALH and distal tubule, urine should be diluted to a value 
of 16.7 to 33.4 l. For testing nucleation occurring in 
the DLR, urine must be diluted to a volume of 16. 7 to 
58.5 l, after removal of THP and other compounds en-
tering the urine after the proximal tubule. 
The clinical use of the model lies in visualizing the 
effects of specific conditions and (therapeutic) actions. 
A high Ca-load, with relative constant serum Ca, does 
not influence the calcium concentrations nor the chances 
for nucleation up to the distal tubule. Conditions involv-
ing an increased serum-Ca do increase the chances of 
nucleation in the LH. A load of oxalate or PO4 directly 
increases the chance for nucleation. An increase in fil-
tered oxalate occurring after ingestion of food with a 
high oxalate content, like chocolate [5], almost triples 
the RS with COM. This will cause formation of calci-
um oxalate crystals to occur earlier in the nephron. In 
extreme cases, induced in rat studies, calcium oxalate 
crystals are found in the proximal tubule already [35]. 
A load with uric acid will increase the likelihood of 
sodium urate formation in the LH and ofUA crystalliza-
tion further in the nephron. The effects of an acid load 
are more complicated. Acid loading causes an increased 
citrate resorption proximally. Since citrate acts as an 
inhibitor of calcium salt nucleation, this decrease in 
concentration increases the chance of apatite and calcium 
oxalate nucleation in the LH. In the distal tubule and 
further on, calcium reabsorption is decreased and acidifi-
cation increased. On one band, this lowers the rate of 
HAP crystallization, counteracting the effect of a lower 
citrate. On the other hand, conditions of lower pH, 
lower citrate concentration and higher calcium concen-
tration, increase the self-aggregation of THP [27]. This 
decreases the ability of the urine to inhibit crystal ag-
glomeration [19, 27]. Obviously, alkali loading, asap-
plied to the treatment of calcium oxalate urolithiasis 
[51], bas the reverse effects. It decreases the likelihood 
of HAP crystallization in the LR, due to the increased 
citrate excretion. In the distal tubule and further, the 
effect on HAP crystallization of an increased citrate con-
centration is counteracted by an increased pH. The 
main beneficial effect of alkali therapy may be the 
changed conditions in the CD, higher citrate, and higher 
pH, which increase the inhibition of crystal agglomera-
tion at that site [19, 27, 34]. 
Even more complicated are the effects of a high in-
take of animal protein. An animal protein load increases 
calcium excretion [10, 56] and acts as an acid load [39], 
with the same negative effects. In addition, it will cause 
an increase in uric acid excretion [12], which further in-
creases the likelihood of nucleation and crystal agglom-
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eration. Also, phosphate excretion is increased [37], 
causing increased supersaturation with HAP in the LH. 
When an animal protein load is combined with an in-
creased sodium chloride intake, the increased ionic 
strength in the collecting ducts provides an additional 
factor for promoting THP self-aggregation and increas-
ing crystal agglomeration. This may explain the exag-
gerated decrease in crystal agglomeration inhibition 
found in urines of persons receiving a combined protein 
salt load [39]. 
A special case of acidification effects is posed by 
renal tubular acidosis (RTA). Normally, with acid load-
ing, the decrease in pH distally acts to decrease the 
propensity for HAP crystallization. With RTA, the de-
crease in citrate is not compensated by a decrease in pH; 
consequently, CaP crystallization is more likely to con-
tinue in the distal tubule and further on. 
Thiazide treatment increases calcium reabsorption in 
the distal tubule. Thus, this will not affect the chances 
of nucleation in the LH. The reduced calcium in the 
distal tubule and CD does, however, decrease the rate of 
crystallization there and diminishes the propensity for 
THP self-aggregation. 
Also interesting are the effects of water loading. 
The concentrations in the proximal tubule and DLR are 
relatively independent of the hydration state of the body. 
In the CD, however, a water load will strongly increase 
the urine flow and decrease the possibility of large par-
ticle retention by increased shear forces and decreased 
residence time. Additionally, the higher dilution de-
creases the propensity for THP self-aggregation and 
crystal agglomeration. 
The model also points to what value urine parame-
ters actually have. Citrate and oxalate values give infor-
mation on chances for crystallization throughout the 
nephron. Measuring urine volume is relevant for what 
happens in the collecting ducts, pelvis and bladder. The 
interpretation of urine calcium values depends on the 
source of the calcium, hypercalcemia or dietary loading. 
Measuring crystal growth and crystal agglomeration ef-
fects in undiluted urine bears relevance to the pelvic and 
bladder situation. Measuring these parameters, using 
urines diluted between 1:2 to 1:9 times, is relevant for 
describing the events in the IMCD and duct of Bellini, 
where in vivo agglomeration probably plays its biggest 
role. 
The model also points to the relevance of some 
structural kidney features. When retention occurs in the 
LH or distal tubule, the main mechanism seems to be 
fixation of crystals to the cells lining the segments. 
Interesting in this respect is that THP and NC, which 
are thought to play a role in stone formation, are pro-
duced by cells at these sites. Tamm-Horsfall protein is 
expressed on the membrane in the ALH and the early 
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parts of the distal tubule, and is thought to form a water 
impermeable layer. This property might also play a role 
in repelling crystals. Changes in the density or the 
structure of membrane-bound THP might contribute to 
increase.d adherence. 
Another structural feature which plays a role is the 
natural-occurring variety in length of the LH. The 
length can vary from 33 to 140 mm. When the length 
of the loop increases, two risk factors increase as well . 
First, the urinary saturation with calcium salts increases 
with increasing loop-length. This is somewhat counter-
acted by the increasing ionic strength. However, espe-
cially in the LDLH, sodium chloride is also resorbed. 
Second, the passage time of the urine and the particles 
formed in it increases because of both the increase.d 
length and the reduced volume, thus reduced flow of 
urine. The presence of more, longer loops and condi-
tions where preferentially more long loops are used 
might thus be considered risk factors for nephrolithiasis. 
In the development of human kidneys, growth continues 
until adulthood, mainly due to elongation of the proxi-
mal tubule and LH. This continuous increase in long 
loops may be relevant to the finding that the incidence 
of stone formation before adulthood is low and reaches 
its peak in the second decade of life. 
Concluding, the model presented here may help in-
vestigators by clearly defining the conditions occurring 
at the site of nephrolithiasis. 
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Discussion with Reviewers 
S.R. Khan: Nucleation experiments were carried out in 
inorganic solutions without the proteins which are gener-
ally present in the urine. Do you think calcium phos-
phate will crystallize in the presence of these proteins in 
the Loop of Henle? 
Author: At the tip of the Loop of Henle, one may ex-
pect membranous material, crystal matrix protein (uri-
nary prothrombin fragment 1), nephrocalcin and proteins 
I am not aware of. In the discussion, I have pointed out 
that the concentration of nephrocalcin in the Loop of 
Henle will be at least 2 to 10 times below the concentra-
tion needed to decrease the rate of nucleation by 42 % . 
Actually, at the tip of the Loop of Henle, the induction 
time is less then 3 seconds compared to the transit time 
through the ascending limb of the Loop of Henle of 100 
seconds. The nucleation rate would need to be de-
creased more then 95 % to completely prevent nuclea-
tion. I have no assessment on the concentrations of 
crystal matrix protein and membranous material at the 
site, nor about how the balance of counteractive actions 
would be. 
S.R. Khan: Renal papillary surface epithelium may 
also be involved in urine concentration. What will be its 
effect on urolithiasis? 
Author: Given the high flow rate through the Duct of 
Bellini, I am not convinced that changes in urinary con-
centration can play a dominant role there. This may be 
different when you consider that the ducts may be closed 
at times at those sites. I do not know how to fit this into 
the model. Finally, I see a role for damaged epithelium, 
where the chance of particle adhesion may be increased. 
J.P. Kavanagh: How well can one make quantitative 
estimates for average human nephrons from measure-
ments using individual animal nephrons? 
Author: As mentioned in the text, extrapolating the ani-
mal data to the human situation poses a potential error. 
For the sake of the model, however, I feel that when the 
precaution is taken to use ranges of values including the 
extreme low and high values, in most cases, the "hu-
man• situation will be included. 
J.P. Kavanagh: Using average data may tell us some-
thing about the normal possibility of nucleation events in 
Urolithiasis 
different nephron segments, but it may be important to 
consider the nucleation behaviour at all extremes of ana-
tomical and excretory patterns. Lack of nucleation in 
average nephrons does not necessarily mean its absence 
in all, and one burst of nucleation may be sufficient to 
initiate a stone. 
Author: This is completely true. For this reason, I 
explicitly dealt with the situations of extreme high 
excretions of oxalate and phosphate and distinguished 
between types of nephrons. 
J.P. Kavanagh: You note that a pH change of 0.03 can 
cause an 8-fold change in nucleation lag-time which 
might cause one to conclude that in one case, nucleation 
might occur in the Loop of Henle, while in another case, 
it would not. This emphasizes how critical the choice of 
experimental conditions is and, of course, the danger of 
trying to extrapolate the in vitro findings to in vivo 
interpretations. Can this be done with any confidence? 
Author: At the calcium and phosphate concentrations 
probably existing at the bend of a short Loop of Henle, 
variations around the probable pH-value there, 7.20, are 
very critical for HAP-nucleation. At the higher concen-
trations existing at the bend of a long Loop of Henle and 
the higher pH there, 7.4, small variations in pH play no 
role for HAP-nucleation and absolutely no role for cal-
cium oxalate nucleation. Thus, it seems safe to extra-
polate these findings to the in vivo situation. 
C.R. Scheid: The site of nephrocalcin production is not 
known with certainty, and local concentrations may 
vary. Could you explain bow you get to the statement 
that NC levels in the LDLH will be too low to act as an 
effective inhibitor of nucleation? 
Author: I described in the Data Used section that the 
production site of NC bas been suggested to be in the 
proximal and/or distal tubule. If NC is produced only 
in the distal tubule, the concentration in the Loop of 
Henle will be zero. Since I do not know where it is 
produced, I assumed the production occurs 50 % in the 
proximal tubule and 50 % in the distal tubule. When all 
NC would be produced in the proximal tubule, the con-
centrations in the Loop of Henle would be twice those 
mentioned in the text and still below what would be 
needed to increase the lag-time from less then 3 seconds 
to the needed 100 seconds ( > 95 % reduction of the nu-
cleation rate). Of course, it is also possible that NC is 
produced in only a few proximal tubules. This might 
bring the NC-concentration into the needed concentration 
range. One should also consider the counteractive action 
of membranous material deriving from the proximal 
tubule. 
C.R. Scheid: Why does Figure 2 differ so markedly 
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from Figure 1? Fluid remains isoosmotic in the early 
regions of the nephron. Variations in urine volume do 
not reflect differences in the relative dilution of urine in 
the ultrafiltrate (as inferred in Fig. 2). Will the use of 
these values not affect subsequent calculations as to 
where crystals are likely to form? 
Author: In Figure 1, the lines represent absolute num-
bers for volume at specific sites. Figure 2 is drawn for 
the sake of experimental design and shows the dilution 
at a specific point relative to the 24-hr volume. Four 
different values of 24-hr volume were used. The aim of 
Figure 2 is to show how much the fluid at a given point 
is diluted compared to the end product, the 24-hr urine. 
The lines are not related to the ultrafiltrate conditions. 
Where relevant, I used the both the lower and upper 
ends of ultrafiltrate ranges to calculate which effects 
these variations have further on in the nephron. I agree 
that much more detail can be put into the model and I 
hope that this will be done in the ensuing discussions 
you predict. 
W.C. de Bruijn: In the description of the crystalli-
zation experiments, urines were used undiluted and 5 
times diluted. In Results, you showed in Figure 3 the 
results from undiluted urine but failed to show the 5 
times diluted and mentioned dilutions from 2 to 50 times 
for the DHL and CD parts. Does this mean that beyond 
the Loop of Henle, calcium oxalate crystal formation can 
be ignored? 
Author: I performed experiments with undiluted urines 
to show that crystallization proceeds exceedingly slow 
under those conditions. I did not include the experi-
ments with 1:5 diluted urines (which have been part of 
many previous publications from our group) here, since 
they do not contribute to the message. From the model 
presented here, it follows that using undiluted urines in 
fact is representative for what happens in the bladder. 
Should one want to test what happens earlier, in the 
Loop of Henle or the collecting ducts, one should apply 
the dilutions mentioned in the text. I did not perform 
these experiments since it was not the aim of this work. 
I also do not conclude that beyond the Loop of Henle no 
calcium oxalate nucleation occurs. In fact, calcium oxa-
late nucleation is likely to occur in the collecting ducts. 
W.C. de Bruijn: In the Introduction, you narrowed 
down stone formation to free particle retention of parti-
cles too large to be excreted and fixed particle retention 
to the epithelial cell surface coat materials at sites with 
poor flow conditions. Do you hold the view that the 
step from crystals to stones is a pure intra-tubular crys-
tallization process or that crystal retention (either the 
former or the latter) is a prerequisite for stone formation 
either interstitially or at papillary sites? 
D.J. Kok 
Author: The fixed particle mechanism is an interplay 
of particle size, interactions between particles and cells 
and particle removal. The fixed particle mechanism 
may be enhanced by increased sticking of particles due 
to particle size, by increased adhesion of particles to 
cells (due to different coating of the particles and/or the 
cells) and by deficient removal of particles (by shear 
forces or actively by the kidney cells). 
W.C. de Bruijn: In your proposed nephrolithiasis 
model, nephrons are differentiated in a longitudinal 
sense. In rat experiments, we found that not all neph-
rons were responding alike to a generalized chronic (cal-
cium oxalate) challenge (de Water et al., unpublished). 
Could you speculate about the chances that in human 
stone-formers there is also a lateral differentiation (that 
is to say, a complete renculus or even one of the two 
kidneys behaves abnormal)? 
Author: Central to the model is the notion that local 
circumstances play a very important role in stone for-
mation. Local variations in nephron properties, as you 
mention, may very well be important in that respect. 
Reviewer V: Does Figure 5 show all concentrations of 
phosphocitrate at all pH-levels? 
Author: No. I did measure them but at low pH-values, 
no nucleation occurs within 10 minutes at the high PC-
levels (5 and 25 µM) and conversely, at pH values 
above 7.23, the low concentrations of phosphocitrate 
(0.5, 2.5 µM) do not increase the lag-time measurably. 
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